Matthias Brunner Selected Research

Cicatrix (Scar)

10/2018

Regressing Conjunctival Nevus in a Child.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthias Brunner Research Topics

Disease

5	Fibrosis (Cirrhosis) 01/2022 - 01/2018
3	Corneal Neovascularization 09/2018 - 07/2016
2	Rheumatoid Arthritis 11/2023 - 01/2016
2	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2019 - 01/2019
1	Wounds and Injuries (Trauma) 01/2021
1	Systemic Scleroderma (Systemic Sclerosis) 01/2021
1	Hemophilia A (Haemophilia) 08/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2019
1	Idiopathic Pulmonary Fibrosis 01/2019
1	Cicatrix (Scar) 10/2018
1	Infections 10/2018
1	Neoplasms (Cancer) 01/2018
1	Lung Injury 01/2018
1	Keratoconus 12/2017
1	Vasculitis (Vasculitides) 01/2016
1	Acute Retinal Necrosis Syndrome 01/2016
1	Autoimmune Diseases (Autoimmune Disease) 01/2016
1	Virus Diseases (Viral Diseases) 01/2016
1	Scleritis (Episcleritis) 09/2014
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2011

Drug/Important Bio-Agent (IBA)

3	Indocyanine Green (Cardio-Green)FDA LinkGeneric 09/2018 - 01/2018
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 01/2022
1	Proteins (Proteins, Gene)FDA Link 11/2023
1	Metalloproteases (Metalloproteinases)IBA 01/2021
1	Matrix Metalloproteinases (MMPs)IBA 01/2021
1	CytokinesIBA 01/2021
1	CollagenIBA 01/2021
1	emicizumabIBA 08/2020
1	IntegrinsIBA 01/2019
1	somatostatin receptor 2IBA 01/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 01/2019
1	Fluorescein (Funduscein)FDA LinkGeneric 09/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2018
1	indium-bleomycinIBA 01/2018
1	Fos-Related Antigen-2IBA 01/2018
1	Hematoxylin (Haematoxylon)IBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2016
1	AntibodiesIBA 09/2014
1	Therapeutic UsesIBA 09/2014
1	Immunosuppressive Agents (Immunosuppressants)IBA 09/2014
1	Pemetrexed (MTA)FDA Link 12/2011
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 12/2011

Therapy/Procedure

3	Therapeutics 01/2016 - 12/2011
1	General Anesthesia 10/2018
1	Corneal Cross-Linking 12/2017
1	Diathermy 07/2016